JAK2 and cancer: Janus kinase 2 (JAK2) and signal transducer and activator of transcription 3 (STAT3) signaling is an essential pathway in human cancers, as well as CSCs, acting by regulating inflammatory cytokines such as interleukin (IL)-6 [23].